Previous 10 | Next 10 |
Merger activity went on a tear last week with twelve new deals announced and one pending deal closing. Deal Statistics: New Deals: The acquisition of Caesars Entertainment Corporation (CZR) by Eldorado Resorts (ERI) for $17.3 billion in a cash plus stock deal. Under the terms of...
Merger activity remained steady last week with four new deals announced and four pending deals closing. Deal Statistics New Deals The acquisition of LegacyTexas Financial Group ([[LTXB]]) by Prosperity Bancshares ([[PB]]) for $2.1 billion in a cash-plus-stock deal. Under the terms o...
This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position ...
Note: This article was first made available to members of my exclusive community, The Formula , on May 14 when shares of Adverum ( ADVM ) were trading just over $6. Read: Adverum's most quarterly filing Read: ADVM-022 article (preclinical findings) Gene therapy - op...
Merger activity decreased last week with four new deals announced and six pending deals closing. Deal Statistics: New Deals: The acquisition of Tableau Software (DATA) by salesforce.com (CRM) for $15.7 billion in an all-stock deal. Under the terms, if the agreement, each share...
This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position ...
INSYS Therapeutics (NASDAQ: INSY ) -63% on filing Chapter 11 for bankruptcy. More news on: INSYS Therapeutics, Inc., Spark Therapeutics, Inc., Genocea Biosciences, Inc., Stocks on the move, Read more ...
Today's Top Stories: Aerospace and defense merger Monday; at ease; and Mexico tariffs averted. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Alpha Podcasts here ) Stitcher Sou...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). United Technologies and Raytheon have agreed to an all-stock merger, creating the second-largest def...
Roche's ( OTCQX:RHHBY ) $4.3B takeover of Spark Therapeutics (NASDAQ: ONCE ) has been pushed back again, possibly beyond the first half of 2019, as regulators continue to scrutinize the deal for its effect on competition. More news on: Roche Holding AG, Spark Therapeutics, Inc., Roche Ho...
News, Short Squeeze, Breakout and More Instantly...
Spark Therapeutics Inc. Company Name:
ONCE Stock Symbol:
NASDAQ Market:
Spark Therapeutics Inc. Website:
Genetics is the study of genes, their variations and hereditary characteristics. As Live Science describes it , genetics involves looking at how traits are passed on through generations. So, what is genetics investing? When it comes to genetics investing, companies in this niche...
After big biopharma Astellas (OTC: ALPMY) (OTC: ALPMF) agreed to acquire clinical-stage gene therapy company Audentes Therapeutics (NASDAQ: BOLD) for $3 billion in cash, uniQure 's (NASDAQ: QURE) shares have jumped 13% at 12:15 pm EDT on Tuesday. Although Audentes and uni...
PHILADELPHIA, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that the Galien Foundation has awarded the prestigious 2019 Prix Galien USA Aw...